NCT05984459View on ClinicalTrials.gov

Type 2 Diabetes Treatment and Remission With a Very Low-Calorie Ketogenic Diet (VLCKD) and Lifestyle Changes

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

July 20, 2023

Study Completion Date

October 2, 2023

Conditions
Type 2 Diabetes MellitusOverweight and Obesity
Interventions
DIETARY_SUPPLEMENT

VLCKD

The analysis will focus on the observation of the evolution of anthropometric and clinical parameters,such as the improvement or normalization of HbA1c, as well as on the evolution of the hypoglycemic medication between patients who accept VLCKD method

Trial Locations (1)

1003

Dr. Daniela Sofra, Lausanne

Sponsors

Lead Sponsor

Cabinet Medical
All Listed Sponsors
collaborator

Trialance SCCL

INDUSTRY

lead

Cabinet Medical

OTHER

NCT05984459 - Type 2 Diabetes Treatment and Remission With a Very Low-Calorie Ketogenic Diet (VLCKD) and Lifestyle Changes | Biotech Hunter | Biotech Hunter